Introduction {#S1}
============

Senescence is a cellular program characterized by a permanent growth arrest of damaged or aged cells [@R1] [@R2]. Cells undergoing senescence display profound phenotypic changes, which are driven by alterations in metabolism, chromatin organization and transcriptional activity. A prominent hallmark of senescent cells is the secretion of inflammatory mediators, including various cytokines, chemokines, extracellular matrix proteins and growth factors, collectively referred to as the senescence-associated secretory phenotype (SASP)[@R3] [@R4]. Through the secretion of the SASP, senescent cells critically influence many biological processes, including wound healing[@R5], tissue repair[@R6], tumorigenesis[@R7] or *in vivo* reprogramming[@R8]. Moreover, the inflammatory response linked to the SASP is considered to underlie many senescence-associated effects on ageing and age-related disorders [@R9], [@R10] [@R11]. Thus, understanding the regulation of the SASP is essential, both for deciphering the basis of senescent cell communication but also for discovering new targets controlling senescence effector responses. On a molecular level, several transcription factors have been implicated in the up-regulation of SASP-genes including NF-κB, C/EBP-β, p38 MAPK and GATA4 [@R12], [@R13], [@R14], [@R15], [@R16]. However, the upstream signalling pathway(s) that activate these transcriptional regulators within senescent cells remain incompletely characterized.

Inflammation is generally initiated through the activation of innate immune receptors, most mentionable various pattern recognition receptors (PRRs) [@R17]. Despite being best known for the recognition of microbial products in the context of infection, some PRRs can also become activated by aberrant self-molecules. cGAS, which senses double-stranded DNA, represents a well-studied example of a PRR that responds equally to both microbial as well as endogenous DNA ligands [@R18]. Upon activation, cGAS synthesizes the second messenger molecule 2\`3\`cyclic GMP-AMP (cGAMP), which engages STING, thereby leading to the production of inflammatory cytokines, chemokines and type I interferons (IFNs) [@R19] [@R20] [@R21] [@R22], [@R23] [@R24] [@R25]. Although the localization within the cytosol usually prevents an unintended activation of the cGAS-STING signalling pathway, conditions wherein self-DNA gains access to the cytosol can trigger -- occasionally detrimental - inflammatory responses. Genetic defects that compromise endogenous DNA metabolism or instances that trigger massive, synchronized accumulation of dead cells represent examples of this phenomenon [@R26] [@R27] [@R28], [@R29] [@R30]. However, whether self-DNA sensing by cGAS contributes to biological processes in a more "physiological" manner remains unclear.

Here we report a function of innate DNA sensing through cGAS in the regulation of cellular senescence. Specifically, we identified that senescent cells engage the cGAS-STING pathway, thereby regulating the SASP and facilitating paracrine senescence. We demonstrate that the activation of cGAS bases on its recognition of aberrant cytosolic chromatin fragments (CCFs), which arise in senescent cells as a consequence of nuclear lamin B1 degradation [@R31]. We found that diverse triggers of cellular senescence, including oxidative stress, oncogene signalling, irradiation and pro-senescent drugs depend upon cGAS-STING signalling to drive the production of inflammatory SASP components. Finally, we observed that cGAS-triggered senescence occurs upon irradiation and oncogene activation *in vivo*. Together, these findings establish endogenous DNA sensing through the cGAS-STING pathway as an important regulator of senescence and the SASP.

Deficiency of the cGAS-STING pathway impairs oxidative-stress induced senescence {#S2}
--------------------------------------------------------------------------------

While studying the function of cGAS, we repeatedly noticed that upon serial passaging under standard culture conditions mouse embryonic fibroblasts (MEFs) deficient for cGAS (cGAS KO MEFs) exhibited an accelerated proliferation rate compared to wild-type (WT) MEFs. To explore this phenomenon in further detail, we cultured MEFs from an early passage on according to the 3T3 protocol and counted cells over several weeks[@R32]. Comparing cell numbers obtained from the first few passages, we did not observe any difference in the proliferation rate of WT MEFs and cGAS KO MEFs ([Fig. 1a](#F1){ref-type="fig"}). However, after serial passages WT MEFs proliferated less than cGAS KO MEFs ([Fig. 1a](#F1){ref-type="fig"}). Quantifying the proliferation rate by 5-bromo-2\`-deoxyuridine (BrdU) incorporation confirmed the increased replicative activity of cGAS KO MEFs compared to WT MEFs ([Fig. 1b](#F1){ref-type="fig"}). In agreement with a senescent phenotype, WT cells became flat and enlarged and displayed high activity of senescence-associated β-galactosidase (SA-β-Gal) ([Fig. 1c](#F1){ref-type="fig"}). In contrast, cGAS KO MEFs did not acquire these morphological changes and most of them did not become positive for SA-β-Gal ([Fig. 1c](#F1){ref-type="fig"}). To systematically explore the altered phenotype of WT MEFs and cGAS KO MEFs, we performed gene expression profiling with RNA sequencing from cells cultured for 30 -- 42 days. Notably, among the transcripts that showed most increased expression in WT MEFs we found *Cdkn2a* (p16^Ink4a^) and *Cdkn2b* (p15), crucial regulators of the senescent cell cycle arrest in eukaryotic cells ([Fig. 1d](#F1){ref-type="fig"})[@R1], [@R33], [@R34]. Moreover, several genes encoding proteins constituting the senescence-associated secretory phenotype (SASP) were overexpressed in WT MEFs relative to cGAS KO MEFs (*Igfbp6*, *Ccl7, Vcam1, Csf1*) ([Fig. 1d](#F1){ref-type="fig"})[@R3]. Conversely, genes with decreased expression in WT MEFs were enriched for transcripts related to mitosis and many of those are known targets of retinoblastoma (RB)-dependent E2F transcription factors (*Mcm5, Top2a, Melk, Bub1b, Ccna2, Smc4, Bub1*) ([Supplementary Fig. 1a](#SD2){ref-type="supplementary-material"})[@R35]. Direct measurement of the expression of p16^Ink4a^ and other senescence markers confirmed the results obtained by RNA sequencing ([Fig. 1e, f](#F1){ref-type="fig"}). Similar to cGAS, deficiency of STING resulted in an accelerated proliferation rate and compromised the induction of markers related to senescence ([Supplementary Fig. 1b, c, d](#SD2){ref-type="supplementary-material"}). Together, these data suggest that the cGAS-STING signalling pathway acts as a positive regulator of senescence in MEFs.

Oxidative stress has been implicated as a cause of premature senescence of MEFs *in vitro*[@R36]. The above findings led us to investigate whether cGAS contributes to oxidative stress-induced senescence. To accelerate the induction of oxidative stress-induced senescence, we incubated MEFs under 40% O~2~ and monitored senescence markers after 7 days. Consistent with the pro-senescent activity of oxidative stress, we found that WT MEFs rapidly entered senescence as indicated by increased activity of SA-β-Gal, elevated expression of p16^Ink4a^ and decreased proliferative activity ([Fig. 2a, b, c, d](#F2){ref-type="fig"}). Conversely, cGAS KO MEFs and STING KO MEFs exhibited a compromised senescence phenotype ([Fig. 2a, b, c, d](#F2){ref-type="fig"}). To determine whether cGAS also influences oxidative stress-induced senescence in human cells, we depleted cGAS in WI-38 cells and examined markers of senescence ([Fig. 2e](#F2){ref-type="fig"}). Indeed, upon oxidative stress exposure, knockdown of cGAS prevented SA-β-Gal activity and p16^Ink4a^ expression compared to cells treated with a non-targeting control siRNA ([Fig. 2f, g, h](#F2){ref-type="fig"}). Together, these findings suggest that cGAS and STING regulate oxidative-stress induced senescence.

The cGAS-STING pathway promotes senescence in a paracrine manner {#S3}
----------------------------------------------------------------

We next sought to determine how cGAS controls senescence. In the context of innate immunity the central function of the cGAS-STING pathway is the secretion of antiviral and inflammatory cytokines and chemokines. We therefore suspected that cGAS and STING might promote senescence indirectly through regulating the SASP [@R37] [@R38]. Indeed, we found that conditioned medium (CM) from WT MEFs exposed to oxidative stress promoted a senescence response (as indicated by decreased BrdU incorporation and increased SA- β-Gal activity) within both WT MEFs as well as cGAS KO MEFs ([Fig. 3a, b](#F3){ref-type="fig"} and [Supplementary Fig. 2a, b](#SD3){ref-type="supplementary-material"}). In contrast, CM from cGAS KO MEFs cultured under the same conditions failed to arrest MEFs ([Fig. 3a, b](#F3){ref-type="fig"} and [Supplementary Fig. 2a, b](#SD3){ref-type="supplementary-material"}). To better characterize the SASP components, which are controlled by cGAS, we analysed the CM from both WT MEFs and cGAS KO MEFs using a cytokine array. Remarkably, the secretion of several distinct SASP factors including IL-6, TNF-α and several chemokines depended on cGAS ([Fig. 3c](#F3){ref-type="fig"}). Moreover, the production of Cxcl-10, a well-known cGAS-dependent interferon-stimulated gene (ISG), was reduced in cGAS KO MEFs relative to WT MEFs ([Fig. 3c](#F3){ref-type="fig"}). Similarly, depletion of cGAS in WI-38 cells decreased the secretion of SASP components, most prominently IL-6 ([Supplementary Fig. 2c](#SD3){ref-type="supplementary-material"}). We confirmed that the cGAS-STING signalling pathway is required for the expression of SASP factors (IL-6) and for the induction of ISGs (Ifi44) from both MEFs as well as WI-38 cells undergoing oxidative stress-induced senescence ([Fig. 3d, e](#F3){ref-type="fig"} and [Supplementary Fig. 2d, e](#SD3){ref-type="supplementary-material"}).

The induced expression of ISGs along with the reported role of type I IFNs in senescence, prompted us to examine whether cGAS-mediated secretion of type I IFNs is involved in promoting oxidative stress-induced senescence [@R39], [@R40], [@R41], [@R42]. We found that addition of recombinant IFN-β to cultures of WT MEFs and cGAS KO MEFs was sufficient to induce SA-β-Gal activity and p16^Ink4a^ expression and to promote cell cycle arrest ([Fig. 3f, g](#F3){ref-type="fig"} and [Supplementary Fig. 2f, g](#SD3){ref-type="supplementary-material"}). Conversely, MEFs deficient for the type I IFN receptor (IFNAR KO MEFs), displayed a compromised oxidative stress-induced senescence response (SA-β-Gal activity, BrdU incorporation, p16^Ink4a^ expression, IL-6 production, ISG induction) compared to WT MEFs ([Fig. 3h, i, j](#F3){ref-type="fig"} and [Supplementary Fig. 2h](#SD3){ref-type="supplementary-material"}). Collectively, these data suggest a possible role for type I IFNs in relaying cGAS-mediated senescence. However, additional cGAS-dependent SASP factors or activities most likely further enhance the senescent phenotype.

CCFs are recognized by cGAS in senescent cells {#S4}
----------------------------------------------

We next sought to characterize the DNA source responsible for the activation of cGAS in senescent cells. Degradation of the nuclear envelope component lamin B1 and the occurrence of cytosolic chromatin fragments (CCFs) are well-described features of senescent cells [@R43] [@R31]. In accordance with this, we found decreased expression of lamin B1 in senescent cells ([Fig. 4a, b](#F4){ref-type="fig"}). Furthermore, using confocal fluorescence microscopy, we observed DNA-containing blebs budding of the nucleus as well as characteristic CCFs in cells undergoing oxidative-stress induced senescence ([Fig. 4c](#F4){ref-type="fig"}). We thus hypothesized that the herniation of nuclear DNA into the cytosol might represent the trigger for provoking cGAS-STING signalling in senescent cells. In order to investigate this, we reconstituted cGAS KO MEFs with a doxycycline (Dox)-inducible FLAG-tagged cGAS construct (MEFs Tet-cGAS-FLAG). Remarkably, in cells undergoing oxidative stress-induced senescence, cGAS formed clusters that co-stained with DAPI-positive chromatin herniations ([Fig. 4d](#F4){ref-type="fig"}). Likewise, endogenous cGAS co-localized with chromatin fragments at the nuclear-cytosolic border in senescent WI-38 cells ([Supplementary Fig. 3](#SD4){ref-type="supplementary-material"}). To assess whether the loss of nuclear integrity might itself be sufficient to activate cGAS-STING signalling, we knocked down lamin B1 with two distinct siRNAs in primary MEFs ([Fig. 4e, f](#F4){ref-type="fig"}). Down-regulation of lamin B1 induced leakage of chromatin into the cytosol ([Fig. 4g](#F4){ref-type="fig"}). More important, MEFs with reduced expression of lamin B1 displayed an elevated ISG response (Ifi44 induction), which was dependent on cGAS ([Fig. 4e](#F4){ref-type="fig"}). Thus, it appears that the mere de-stabilization of the nuclear membrane is sufficient to engage cGAS. Consistent with this idea, we observed that cGAS enriched on chromatin containing blebs in cells knocked down for lamin B1 ([Fig. 4g](#F4){ref-type="fig"}). Together, these results suggest that activation of cGAS in senescent cells is caused by its interaction with endogenous DNA arising from defective, senescent nuclei.

Diverse triggers of cellular senescence engage the cGAS-STING pathway {#S5}
---------------------------------------------------------------------

Numerous stressors are able to induce senescence by signalling through various distinct pathways[@R1], [@R2], [@R33]. We therefore sought to determine whether the activation of cGAS is a common feature of senescent cells. To this end, we exposed WT MEFs, cGAS KO MEFs and STING KO MEFs to distinct senescence inducing stimuli and compared the expression of SASP components (IL-6, Cxcl10). We tested ionizing radiation (12 Gy) and palbociclib (PD-0332991), a CDK4 inhibitor, which mimics the effect of p16^Ink4a^. Of note, the production of IL-6 or the induction of Cxcl10 was largely abolished in cGAS KO MEFs or STING KO MEFs ([Fig. 5a](#F5){ref-type="fig"}). To complement the findings with human cells, we explored the impact of cGAS on the induction of IL-6 and Cxcl10 in WI-38 cells undergoing irradiation-induced (12 Gy) or oncogene-induced (HRasV12) senescence. For both triggers and similar to MEFs, the up-regulation of IL-6 and Cxcl10 from WI-38 cells was dependent on cGAS ([Fig. 5b](#F5){ref-type="fig"}). This shows that the cGAS signalling pathway contributes to the production of cytokines from senescent cells, whether induced by irradiation, by oncogene activation or pharmacologically. Despite severely affecting the production of SASP components, cGAS and STING only partially influenced the induction of SA-β-Gal activity in MEFs undergoing irradiation- or palbociclib-dependent senescence, suggesting differences in the extent to which MEFs rely on paracrine senescence, at least in these *in vitro* contexts ([Supplementary Fig. 4a](#SD5){ref-type="supplementary-material"}). In contrast, depletion of cGAS in WI-38 cells impaired the propagation of senescence following irradiation or HRasV12 signalling, as revealed by diminished SA-β-Gal activity and impaired p16^Ink4a^ induction in cells knocked down for cGAS ([Supplementary Fig. 4b, c](#SD5){ref-type="supplementary-material"}). Using fluorescence microscopy, we determined that all treatments from above triggered the degradation of lamin B1, suggesting that the loss of nuclear envelope integrity is a common substrate for the activation of cGAS in these contexts ([Fig. 5c, d](#F5){ref-type="fig"}). To further substantiate the direct involvement of cGAS, we visualized the distribution patterns of nuclear DNA in relation to cGAS. Remarkably, both Dox-treated Tet-cGAS-FLAG MEFs and WI-38 cells displayed an overlay between herniated chromatin and cGAS after irradiation or following treatment with palbociclib or HRasV12 signalling ([Fig. 5e](#F5){ref-type="fig"} and [Supplementary Fig. 4d](#SD5){ref-type="supplementary-material"}). Thus, a diverse range of distinct senescence inducers engages cGAS, which is required for the induction of SASP components.

cGAS regulates cellular senescence *in vivo* {#S6}
--------------------------------------------

Finally, we explored whether the cGAS-mediated regulation of senescence also occurs *in vivo*. To this end, we exposed mice to total body irradiation and examined the induced expression of IL-6, Cxcl10 and Cdkn2a in the lung[@R44]. Although, at 24 h post irradiation, the abundance of ISGs was less in irradiated cGAS KO mice or STING KO mice, Cdkn1a was induced to a similar extend in WT mice, cGAS KO mice or STING KO mice, indicating that cGAS and STING do not influence the *in vivo* DNA damage response ([Supplementary Fig. 5a](#SD6){ref-type="supplementary-material"}). As expected, at this early time point Cdkn2a levels were not detectable. However, 16 weeks after irradiation WT mice expressed Cdkn2a in the lung ([Fig. 6a](#F6){ref-type="fig"}). Strikingly, the up-regulation of Cdkn2a was reduced in both cGAS KO and STING KO mice. We also noted decreased expression of IL-6 and Cxcl10 in cGAS KO and STING KO mice when compared to WT mice ([Fig. 6a](#F6){ref-type="fig"}).

To corroborate the effect of cGAS on the senescence response *in vivo*, we employed a model of oncogene-induced senescence, wherein oncogenic Nras^G12V^ is stably delivered into mouse livers by hydrodynamic injection of transposable elements [@R7]. Both WT mice and cGAS KO mice were injected with transposons encoding Nras^G12V^ and markers of senescence were analysed 6 days later. Delivery of transposable elements encoding for a signalling-defective Nras^G12V^ mutant (^NrasG12V/D38A^) served as a control. Interestingly, despite similar expression of Nras^G12V^ in both genotypes (as assessed by immunostaining of Nras), livers of cGAS KO mice showed decreased levels of p21 and less activity of SA-β-Gal compared to livers of WT mice ([Fig. 6b, c](#F6){ref-type="fig"}). Moreover, expression of several SASP factors including IL-6 and Cxcl10 was reduced in cGAS KO mice relative to WT mice ([Fig. 6d](#F6){ref-type="fig"}). As expected, owing to immune mediated clearance, WT mice showed a reduction of Nras-positive cells after 12 days ([Supplementary Fig. 5b](#SD6){ref-type="supplementary-material"}) [@R7]. In contrast, no significant decrease of Nras-positive cells was observed in cGAS KO mice, thus suggesting that absence of cGAS affects senescence induction and the subsequent immune cell-mediated clearance of oncogene-activated cells. Taken together, these data indicate that cGAS is important for the regulation of senescence *in vivo*, whether induced through irradiation or oncogenic signalling.

Discussion {#S7}
==========

The secretion of the SASP is a key feature of senescent cells. Through the auto- and paracrine effects of the SASP, senescent cells on the one hand modulate their own cellular behaviour, while on the other hand they also influence their microenvironment. Thus, the SASP is considered as a pivotal effector branch of senescent cells in several physiological and pathological contexts. Here we provide evidence for a contribution of the innate DNA sensor cGAS and its downstream adaptor STING in the regulation of the SASP and show that signalling through this pathway acts to reinforce cellular senescence in a non-cell autonomous manner ([Supplementary Fig. 6](#SD7){ref-type="supplementary-material"}).

Previous work has demonstrated the down-regulation of lamin B1 and the subsequent partial loss of nuclear integrity with the occurrence of CCFs represents a characteristic feature of senescent cells [@R15], [@R31]. Our data showing that these changes in the intracellular compartmentalization are connected - via cGAS/STING -- to the induction of an inflammatory response, illustrate its functional consequences for cellular senescence. Interestingly, despite the immediate activation of multiple stress pathways, the emergence of the SASP is considered as a relatively late event in the development of senescence -- usually requiring multiple days to arise [@R45]. Our finding that stimulation of the cGAS/STING pathway occurs through the recognition of CCFs in cells, which are already on the "senescence track", provides one possible explanation of how a senescence-specific inflammatory SASP-response may be initiated.

It is well established that the SASP functions as a strong amplifier of senescence. The findings presented here suggest that the cGAS-STING pathway regulates cellular senescence predominantly through the secretion of soluble factors and by involving auto- and paracrine signalling. First, unbiased examination of the cGAS-controlled secretome showed that many inflammatory cytokines and chemokines associated with promoting senescence depended on cGAS. Second, experiments using conditioned medium, best revealed that the presence of cGAS was crucial to render a senescent cell\`s secretome "pro-senescent". Conversely, loss of cGAS did not influence the responsiveness of recipient cells in committing to paracrine senescence. Consistent with a SASP-mediated regulation of senescence, we found that stimulation of cells with palbociclib, which directly engages the p16 pathway, triggered SA-β-Gal activity largely in a cGAS/STING-independent fashion, yet still depended on the latter genes for the production of inflammatory cytokines and chemokines.

We also explored specific factors that might mediate paracrine senescence. Consistent with previous reports, we found a contribution of type I IFNs in facilitating senescence [@R39], [@R40], [@R41] [@R42]. However, at least *in vitro*, type I IFNs - on their own - were less potent in triggering senescence compared to the more complex SASP present in the secretome of senescent cells. Thus, rather than a single factor, it is the joint action of several mediators that synergize to promote cGAS-dependent senescence.

We also found that loss of cGAS-STING-signalling compromised the senescence response in two distinct models of cellular senescence *in vivo*. Given that the decreased expression of senescence markers (SA-β-Gal or Cdkn2a) paralleled with reduced levels of inflammatory mediators, it is likely that the absence of cGAS/STING-dependent SASP factors accounts for the reduced *in vivo* senescence response.

In conclusion, our study reveals a key role of innate DNA sensing in controlling cellular senescence. Based on our work, we propose that beyond acting as a system to defend against infection, the cGAS-STING pathway may also serve as a cell-intrinsic surveillance system that protects an organism against the deleterious consequences of (pre-) neoplastic cells. Indeed, senescence is well described to function as a potent anticancer mechanism: First, by imposing a permanent cell cycle arrest, cellular senescence prevents the proliferation of damaged and potentially mutated cells. Second, by secreting cytokines and chemokines, senescent cells recruit immune cells, thereby facilitating their own elimination [@R7], [@R46]. Given its role in the immune cell-mediated clearance of pre-malignant cells, as indicated by our study, we speculate that the cGAS-STING pathway may function to promote cell extrinsic antitumor effects.

In addition to these beneficial effects, however, cellular senescence is also implicated in ageing[@R45] and various age-related pathological conditions, including as recently reported atherosclerosis[@R47] or osteoarthritis[@R48]. Because of its prominent role in stimulating an inflammatory response, cGAS and STING may participate in these and other adverse effects of senescence *in vivo*, a point, which will need to be addressed by future studies.

Methods {#S8}
=======

Cell culture {#S9}
------------

MEFs were generated by standard methods from wild type, STING-deficient or cGAS-deficient mice. Detailed laboratory protocols are available upon request. All mice were on the C57Bl/6 background and obtained from both genders. *Tmem173*^-/-^ (STING-deficient) mice were a gift from J Cambier [@R49]. *Mb21d1*^-/-^ (cGAS knockout first) mice were described in [@R50]. *Ifnar1^-/-^* were a gift from C Reis e Sousa and were originally described in [@R51]. This work was performed in accordance with the UK Animals (Scientific Procedures) Act 1986 and institutional guidelines for animal care. This work was approved by a project license granted by the UK Home Office (PPL No. 40/3583) and was also approved by the Institutional Animal Ethics Committee Review Board at the University of Oxford. Cells were cultured under 5% CO~2~ and 5% O~2~ at 37°C in Dulbecco's modified Eagle medium (DMEM) (Life Technologies) containing 10% (v/v) fetal calf serum (FCS), 1% (v/v) penicillin (100 IU/ml)/streptomycin (100 μg/ml), 4.5 g/l D-glucose and 2 mM L-Glutamine. In some experiments MEFs were incubated at ambient O~2~ or 40% O~2~. Cells were repeatedly tested for mycoplasma using specific primers. WI-38 cells were purchased from ATCC CCL-75™ and cultured in DMEM supplemented with 10% (v/v) FCS and 1% (v/v) penicillin (100 IU/ml)/streptomycin (100 μg/ml). No method of cell line authentication was used.

Proliferation curves and SA-β-Gal assays {#S10}
----------------------------------------

Populations of primary MEFs (2 x 10[@R5] per 10 cm dish) were counted by trypan blue exclusion every third day. SA-β-Gal staining was performed according to the manufactures instructions (Cell Signaling, SA-β-Gal staining kit (\#9860)) and images were acquired with a stereomicroscope (Leica MZ 16 1FA). DAPI staining was used to identify nuclei.

For FACS-based determination of senescence, lysosomal alkalinization was induced by treating cells with 100 nM bafilomycin A1 for 1 h in fresh cell culture medium (2 ml per 35 mm dish) at 37 °C. 33 μl of 2 mM C12FDG (Thermofisher, ref. D2893) working solution was added to the cell culture medium to obtain a final concentration of 33 μM. After 1h of incubation, cells were washed, trypsinised and collected on a Gallios flow cytometer (Beckman Coulter) using Kaluza Acquisition software. Data were analysed with FlowJo software.

Generation of conditioned medium {#S11}
--------------------------------

The indicated cells (1×10^6^) were seeded in a 10cm dish and incubated for 7 days in DMEM with 5% FCS in a 40% O~2~ incubator. After incubation, the conditioned medium (CM) was collected, centrifuged at 5,000*g* and filtered through a 0.2μm pore filter. CM was mixed with DMEM 40% FBS in a proportion of 3 to 1 to generate CM containing 10% FBS.

Antibodies {#S12}
----------

Detailed information on the antibodies used including their resources (company names, catalog numbers) and dilutions are provided in [Supplementary Table 2](#SD11){ref-type="supplementary-material"}.

Immunoblots {#S13}
-----------

Cell pellets were lysed in a lysis buffer containing 0.5% Triton X-100, 20 mM HEPES (pH 7.4), 150 mM NaCl, 1.5 mM MgCl~2~, 2 mM EGTA, protease and phosphatase inhibitors (Protease Inhibitor Cocktail I, Animal-Free CALBIOCHEM). Protein concentration was measured using the BCA Pierce Protein assay kit and normalized to the lowest concentration. Samples were diluted with a loading buffer (100 mM Tris HCl (pH 6.8), 10% (v/v) SDS, 20% (v/v) glycerol, bromophenolblue and 4% β-mercaptoethanol). The primary antibody was incubated in 0.1% NFDM for 16 h at 4°C. The secondary antibodies anti-mouse or anti-rabbit HRP-conjugated antibodies were incubated for 1 h at room temperature. Proteins were visualized with the enhanced chemiluminescence substrate ECL (Pierce, ThermoScientific) and imaged using the ChemiDoc XRS Biorad Imager and Image Lab Software. Imaging was performed in two channels: Chemiluminescence and colorimetry, merged together in [Supplementary Figure 7](#SD8){ref-type="supplementary-material"} for uncropped images.

Immunofluorescence {#S14}
------------------

Cells were seeded onto coverslips at a density of 75'000 cells per coverslip and fixed with 2% (v/v) paraformaldehyde for 10 min, permeabilized for 5 min in 0.1% (v/v) Triton X-100 and blocked with 2% BSA in PBS for 20 min at room temperature. Cells were incubated with the primary antibody in PBS containing 2% (v/v) BSA for 1 h at room temperature in a humid chamber. After washing cells were incubated with the secondary antibody in PBS containing 5 μg/ml 4,6-diamino-2-phenylindole (DAPI) for 1 h at room temperature. Coverslips were mounted with Dako (fluorescent mounting medium). Images were acquired by a wide field fluorescence microscope (Zeiss Axioplan) and processed in ImageJ software. Confocal sections were obtained with a confocal laser scanning microscope (Zeiss LSM700).

Corrected total cell fluorescence {#S15}
---------------------------------

Ten images from lamin B1 stained cells per condition were acquired using a Zeiss LSM 700 confocal with a 63x lens. The corrected total cell fluorescence was determined using imageJ following the methods of [@R52]. Briefly, the integrated density of lamin B1, area and mean grey value from nuclei were measured by imageJ. The corrected total cell fluorescence was calculated using the following formula: CTCF = Integrated Density -- (Area of selected cell x Mean fluorescence of background readings).

BrdU incorporation assay {#S16}
------------------------

Cells plated in 10 cm dishes were incubated with 10 μM BrdU (Sigma-Aldrich) for 3h. Cells were fixed with 70% (v/v) cold ethanol overnight. After washing cells were resuspended in 2 M HCl for 30 min and then incubated in PBS-Tween 0.1% containing anti-BrdU antibodies conjugated to FITC (BD Biosciences, Clone B44) for 1 h. Samples were measured using a Gallios Flow Cytometer (Beckman Coulter). Data were analysed by the Kaluza software (Beckman Coulter).

Click-iT EdU incorporation assay {#S17}
--------------------------------

The Click-iT EdU reaction was performed following the instructions of the Click-iT imaging kit (molecular probes by Life Technologies). Ten images per condition were acquired with a 40x magnification objective. The number of EdU positive cells and DAPI positive cells was determined using imageJ.

Senescence induction {#S18}
--------------------

Palbociclib (PD-0332991 HCl, Selleckchem) was added to the culture medium at a final concentration of 4 μM. Cells (MEFs, WI-38 cells) were irradiated with 12 Gy (RS-2000 X-Ray Irradiator). To induce senescence via oxidative stress MEFs were incubated at 20% and 40% O~2~ for the indicated times. Recombinant IFN-β was obtained form Biolegend and used at the indicated concentrations. Cells were treated with IFN-β every day for two weeks.

WI-38 cells were transduced with a neomycin selectable retroviral vector containing pLNCX2 ER:RAS (addgene, Plasmid \#67844) using polybrene at a concentration of 5 μg/ml. Transduced and neomycin selected WI-38 cells (WI-38 ER:RAS cells) were treated with 500 nM of 4'-hydroxy-tamoxifen (SIGMA) every day. Four days after the experimental start cells were treated with the indicated siRNAs for two days and then processed for analysis. WI-38 cells were incubated at 40% O~2~ or irradiated with 12 Gy, cultured for seven days and then transfected with the indicated siRNAs.

Lentiviral vector production and transduction {#S19}
---------------------------------------------

HEK 293T cells were transfected with pCMVDR8.74, pMD2.G plasmids and the puromycin selectable lentiviral vector pTRIPZ containing the open reading frame of cGAS-FLAG by the calcium phosphate precipitation method. The supernatant containing lentiviral particles was harvested at 48 and 72 h, pooled and concentrated by ultracentrifugation. WT MEFs were transduced with the lentiviral vectors by directly adding 10 μl to the culture medium.

Transfection {#S20}
------------

Cells were transfected with siRNAs using Lipofectamin 2000 reagent (Thermo Fisher Scientific) according to the manufacurer's instruction. Silencer select predesigned siRNAs were purchased from Life Technologies. Sequence of mmLmnB1 siRNA Nr. 2: sense: 5' CAUCAGUCAGUUACAAAUATT 3'; antisense: 5' UAUUUGUAACUGACUGAUGTG 3'. mmLmnB1 siRNA Nr. 1: sense: 5' GGAAGUUUAUUCGCUUGAAtt 3'; antisense: 5' UUCAAGCGAAUAAACUUCCca 3'. Human MB21D1 (cGAS) siRNAs were purchased from ThermoFisher Scientific (Cat: AM16708, sicGAS 1 ID: 129125, sicGAS 2 ID: 129126).

Quantitative real-time PCR {#S21}
--------------------------

Cells were lysed with the RLT buffer (Qiagen). RNA was extracted according to the manufacture's protocol (QIAGEN RNeasy Mini kit) and treated with RNase-free DNase (Thermo Scientific). 500 ng of RNA were reverse transcribed (RevertAid, Thermo Scientific) and analysed by RT-qPCR in duplicates using the Maxima SYBR Green/ROX qPCR Master Mix (Life Technologies). The qPCR reactions were run on a 7900HT Fast qPCR instrument or a QuantStudio 5 Real-Time PCR system (Thermo Fisher Scientific). GAPDH was used as a housekeeping gene for normalization

Primer sequences for RT-qPCR:

mm Cdkn2a forward 5' GATTCAGGTGATGATGATGGGC 3';

mm Cdkn2a reverse 5' TGCACCGTAGTTGAGCAGAAG 3';

mm GAPDH forward 5' GTCATCCCAGAGCTGAACG 3';

mm GAPDH reverse 5' TCATACTTGGCAGGTTTCTCC 3';

mm p21 forward 5' CTGGTGATGTCCGACCTGTT 3';

mm p21 reverse 5' TCAAAGTTCCACCGTTCTCG 3';

mm IFI44 forward 5' TGCACTCTTCTGAGCTGGTG 3';

mm IFI44 reverse 5' CCAGCTTGGACTTCACAGGA 3';

mm Cdkn2b forward 5' ACGGAGCAGAACCCAACTG 3';

mm Cdkn2b reverse 5' ATACCTCGCAATGTCACGGT 3';

mm Ccl7 forward 5' GAGGATCTCTGCCACGCT TC 3';

mm Ccl7 reverse 5' ACACCGACTACTGGTGATCC 3';

mm Ccl2 forward 5' CCTGCTGCTACTCATTCACCA 3';

mm Ccl2 reverse 5' ATTCCTTCTTGGGGTCAGCA 3';

mm Igfbp7 forward 5' GCGAGCAAGGGTCTCTGATA 3';

mm Igfbp7 reverse 5' AAGAACACCTTGGCACCAGT 3'

mm Igfbp6 forward 5' GCAGAAGAATCCACGGACCT 3';

mm Igfbp6 reverse 5' GGAACGACACTGCTGCTTTC 3';

mm Cxcl10 forward 5' AAGTGCTGCCGTCATTTTCT 3';

mm Cxcl10 reverse 5' GTGGCAATGATCTCAACACG 3';

hs GAPDH forward 5' GAGTCAACGGATTTGGTCGT 3';

hs GAPDH reverse 5' GACAAGCTTCCCGTTCTCAG 3';

hs CDKN2A forward 5' TCCCTCAGACATCCCCGATTG 3';

hs CDKN2A reverse 5' AAATGAAAACTACGAAAGCGG 3';

hs IL6 forward 5' CCCCTGACCCAACCACAAAT 3';

hs IL6 reverse 5' ATTTGCCGAAGAGCCCTCAG 3';

hs CXCL10 forward 5' AGTGGCATTCAAGGAGTACC 3';

hs CXCL10 rev 5' TGATGGCCTTCGATTCTGGA 3';

hs IFI44 forward 5' GATGTGAGCCTGTGAGGTCC 3';

hs IFI44 reverse 5' CTTTACAGGGTCCAGCTCCC 3';

ELISA {#S22}
-----

Supernatants were harvested and centrifuged at 1'000g to remove cell debris and dead cells. ELISA was performed following the instructions of the Mouse IL-6 ELISA Set from BD Biosciences (BD OpetEIA, Cat. No. 555240).

Cytokine array {#S23}
--------------

Supernatants were harvested from indicated cells and centrifuged at 1'000g to remove dead cells. Cytokines from human cells were analysed following the instructions on Human Cytokine Antibody Array (abcam, ab133997). Cytokines from MEFs were analysed following the instructions of the ProteomeProfiler Array from R&D SYSTEMS. Dot blots were analysed using the plugin MicroArray Profile (OptiNav, Inc.) on Fiji software.

RNA sequencing {#S24}
--------------

RNA was isolated from the WT, cGAS KO MEFs exposed to 20% O~2~ after 33, 36 and 42 days in culture using the RNeasy Mini kit (Qiagen). RNA was further processed for sequencing by the Gene Expression Core Facility GECF (EPFL, Switzerland). mRNA-seq libraries were prepared using the TruSeq mRNA stranded LT (Illumina kit). Samples were sequenced by the NextSeq 500 system sequencing with 1x75 cycle ("single read"), "high output" mode (=expected minimal 400mio reads), chemistry "v2". Sequencing data were processed using HTSstation online software from the Bioinformatics and Biostatistics Core Facility (EPFL, Switzerland). Heat maps were produced from normalized expression data using Cluster 3.0 for computation and JTreeview for visualization.

*In vivo* total body irradiation and oncogene-induced senescence {#S25}
----------------------------------------------------------------

WT, cGAS^-/-^ or STING^-/-^ mice (8-14 weeks of age) were mock-irradiated or exposed to IR (4.25 Gy) and lung tissue was obtained after 24 h or after 16 weeks. Mice from both gender were randomly allocated to different groups and experiments were conducted non-blinded. Mice were maintained under specific pathogen-free (SPF) conditions at Ecole Polytechnique Federale de Lausanne (EPFL), Switzerland. These animal experiments were approved by the Service de la consommation et des affaires vétérinaires (1066 Épalinges, Canton of Vaud, Switzerland). The transposon system encoding for oncogenic Nras^G12V^ or an effector loop mutant incapable of downstream signalling (Nras^G12V/D38A^) were previously described [@R53]. For intrahepatic delivery of the transposon system, mice were hydrodynamically injected with a 5:1 molar ratio of transposon to transposase-encoding plasmid (30 μg total DNA) via the tail vein as previously described. Livers were obtained on day 6 and on day 12 after injection. No statistical method was used to predetermine sample size. The investigators were not blinded to allocation during experiments and outcome assessment. Mice were maintained under specific pathogen-free (SPF) conditions at the University Hospital Tübingen. These animal experiments were approved by the local German authorities of the state of Baden-Wuerttemberg (Regierungspräsidium Tübingen).

Immunohistochemistry {#S26}
--------------------

Immunohistochemical stainings for Nras (clone F155, 1:50, Santa Cruz) and p21 (clone SXM30, 1:100, BD Pharmingen), were performed on paraffin embedded liver sections. SA-β Gal staining on frozen liver sections was performed at pH = 5.5 as previously described [@R54].

Statistics and Reproducibility {#S27}
------------------------------

All experiments were performed three or more times independently under similar conditions, except experiments shown in [Figs 1f](#F1){ref-type="fig"}, [2d, 2e, 2h](#F2){ref-type="fig"}, [3b-j](#F3){ref-type="fig"}, [4a-d](#F4){ref-type="fig"}, [5](#F5){ref-type="fig"} and [Supplementary Figs 1b-d](#SD2){ref-type="supplementary-material"}, [2a-d, 2f-h](#SD3){ref-type="supplementary-material"}, [3](#SD4){ref-type="supplementary-material"}, [4](#SD5){ref-type="supplementary-material"}, [5a](#SD6){ref-type="supplementary-material"} which were performed twice and [Fig 1d](#F1){ref-type="fig"}, [Fig 6](#F6){ref-type="fig"} and [Supplementary Fig 1a](#SD2){ref-type="supplementary-material"} and [Fig 5b](#SD6){ref-type="supplementary-material"}, which were performed once. Statistical significance was calculated by unpaired *t*-test ([Figs 1b, c, e](#F1){ref-type="fig"}, [3h](#F3){ref-type="fig"}, [4b](#F4){ref-type="fig"}, [5c, d](#F5){ref-type="fig"}) or one-way ([Fig 2a](#F2){ref-type="fig"}, [4e](#F4){ref-type="fig"}) and two-way ([Fig 2b, c, g](#F2){ref-type="fig"}, [6a, c, d](#F6){ref-type="fig"}, [Supplementary Fig 2e](#SD3){ref-type="supplementary-material"}, [5a, b](#SD6){ref-type="supplementary-material"}) ANOVA as described in the figure legends. Prism 6 software was used to generate graphs and to perform statistical analysis. *P* values of statistical significance are represented as \*\*\*\* *P* \< 0.0001, \*\*\* *P* \< 0.001, \*\* *P* \< 0.01, \* *P* \< 0.05.

Data availability {#S28}
-----------------

RNA sequencing data have been deposited in the Gene Expression Omnibus (GEO) under the accession code (GSE100102). Source data from [Fig. 1](#F1){ref-type="fig"}-[6](#F6){ref-type="fig"} and [Supplementary Fig.1](#SD2){ref-type="supplementary-material"}, [2](#SD3){ref-type="supplementary-material"}, [4](#SD5){ref-type="supplementary-material"} and [5](#SD6){ref-type="supplementary-material"} are shown in [Supplementary Table 1](#SD10){ref-type="supplementary-material"} or available from the corresponding author on request.
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![Absence of cGAS attenuates the senescence response.\
(**a**) Proliferation curve of primary wild-type (WT) and cGAS knockout (cGAS KO) mouse embryonic fibroblasts (MEFs) cultured under 20% O~2~. (**b**) Percentages of BrdU positive WT or cGAS KO MEFs after 27 days in culture are shown. (**c**) Left: Images of SA-β-Gal stained WT or cGAS KO MEFs at 27 days in culture. Scale bar: 200 µm. Right: Mean and s.d. of the percentages of SA-β-Gal-positive cells are indicated. (**d**) Heat maps of RNA-seq analysis of WT MEFs and cGAS KO MEFs (For each genotype one sample per day; MEFs collected at Day 33, 36, 42). Genes in WT MEFs exhibiting statistically significant (n=3 biological replicates; student *t*-test; *P* \< 0.05), twofold or greater increases relative to cGAS KO MEFs are shown. Senescence markers are highlighted in green. (**e**, **f**) WT MEFs or cGAS KO MEFs were harvested after 3 weeks of culture and expression of depicted genes was measured via RT-qPCR or protein expression was analysed by immunoblotting. One representative experiment out of three (**a**, **c** (left)) or mean and s.d. of n=3 independent experiments (**b**, **c** (right)) or n=3 independent biological replicates (**e**) are shown. *P* values were calculated by unpaired *t*-test (\* *P* \< 0.05, \*\*\* *P* \< 0.001, \*\*\*\* *P* \< 0.0001). Unprocessed original blots are shown in [Supplementary Fig. 7](#SD8){ref-type="supplementary-material"}. Source data are available in [Supplementary Table 1](#SD10){ref-type="supplementary-material"}.](emss-73252-f001){#F1}

![cGAS facilitates oxidative stress-induced senescence.\
(**a**, **b**, **c**, **d**) WT MEFs, cGAS KO MEFs or STING KO MEFs were cultured under hyperoxic conditions (40% O~2~) for 7 days and subsequently stained for SA-β-Gal activity (**a**), examined for percentages of EdU^+^ cells by immunofluorescence (**b**) or assessed for expression of *Cdkn2a* by RT-qPCR (**c)** or p16^Ink4a^ by immunoblotting (**d**). (**e**) WI-38 cells were exposed to 40% O~2~ treatment for 9 days. On day 7 cells were transfected with a non-targeting control siRNA (si Control) or with siRNAs against cGAS (si cGAS \#1, si cGAS \#2). Expression of cGAS was assessed by immunoblotting on day 9. (**f**, **g**, **h**) WI-38 cells were treated as in (**e**). On day 9 SA-β-Gal activity was assessed by FACS (**f**) and expression of *CDKN2A* was examined by RT-qPCR (**g**) or p16^Ink4a^ was assessed by immunoblotting (**h**). Numbers in (**f**) indicate percentages of SA-β-Gal positive cells. Mean and s.d. of n=5 independent experiments (**a**) or n=3 biological replicates (**b**, **c**, **g**) or one representative experiment out of 3 (**f**) or 2 (**d**, **e**, **h**) independent experiments are shown. *P* values were calculated by one-way (**a**) and two-way (**b**, **c**, **g**) ANOVA (\* *P* \< 0.05, \*\* *P* \< 0.01, ns = not significant). Source data are available in [Supplementary Table 1](#SD10){ref-type="supplementary-material"}. Unprocessed original blots are shown in [Supplementary Fig. 7](#SD8){ref-type="supplementary-material"}.](emss-73252-f002){#F2}

![cGAS regulates the senescence-associated secretory phenotype.\
(**a**, **b**) Conditioned medium (CM) was collected from WT MEFs or cGAS KO MEFs exposed to 40% O~2~ for 7 days. Percentages of proliferating cells (WT MEFs) were assessed by BrdU incorporation assay (**a**) or induction of SA-β-Gal activity was determined by microscopy (**b**). (**c**) Cytokine profile of the CM from WT MEFs of cGAS KO MEFs exposed to 40% O~2~ for 7 days. Some SASP factors are highlighted in red. (**d**) WT MEFs, cGAS KO MEFs or STING KO MEFs were incubated in 40% O~2~ for 7 days and IL-6 was quantified by ELISA. (**e**) WI-38 cells were exposed to 40% O~2~ treatment for 9 days. On day 7 cells were transfected with a non-targeting control siRNA (si Control) or with siRNAs against cGAS (si cGAS \#1, si cGAS \#2). Expression of IL-6 was determined by RT-qPCR. (**f**, **g**) WT MEFs and cGAS KO MEFs were cultured in the presence of recombinant IFN-β as indicated for 14 days. Cells were stained for SA-β-Gal (**f**) or cell cycle activity was assessed by EdU incorporation (**g**). (**h**, **i**, **j**) WT MEFs of IFNAR KO MEFs were cultured under 40% O~2~ for 7 days and stained for SA-β-Gal (**h**), proliferative activity (BrdU incorporation) was assessed by FACS at day 4 (**i**) or expression of p16^Ink4a^ was determined by immunoblotting after 7 days (**j**). Mean and SEM of n=3 (**a**) or mean and s.d. of n=4 independent experiments are shown (**h**) or one representative out of 2 independent experiments is shown (**c**, **j**). Data shown in (**b**, **d**, **e**, **f**, **g**, **i**) are from n=2 independent experiments with the column representing the mean. *P* value was calculated by unpaired *t*-test (**h**) (ns = not significant). Source data are available in [Supplementary Table 1](#SD10){ref-type="supplementary-material"}. Unprocessed original blots are shown in [Supplementary Fig. 7](#SD8){ref-type="supplementary-material"}.](emss-73252-f003){#F3}

![cGAS interacts with chromatin fragments in senescent cells.\
**(a)** Lysates from WT MEFs and senescent MEFs were probed for the expression of lamin B1 by immunoblot. (**b**) MEFs (left panel) or WI-38 cells (right panel) were incubated at 40% O~2~ as indicated and expression of lamin B1 in individual cells was determined by confocal fluorescent microscopy (CTCF = Corrected Total Cell Fluorescence). (**c**) Confocal fluorescent microscopy images of WT MEFs cultured for 7 days under 40% O~2~ stained for lamin B1 (red) and DAPI (grey). (**d**) cGAS KO MEFs carrying a Dox-inducible vector expressing FLAG-tagged cGAS were cultured in the presence of Dox overnight. Cells were stained with DAPI (grey) or anti-FLAG antibody (green) and imaged by confocal microscopy. (**e**, **f**) MEFs were transfected with a non-targeting siRNA (si Control) or *Lmnb1*-targeting siRNAs (si Lmnb1 \#1, si Lmnb1 \#2). After 72 h mRNA levels of indicated genes were analysed by RT-qPCR (**e**) or protein expression was determined by immunoblotting after 48 h. (**g**) MEFs carrying a Dox-inducible vector expressing FLAG-tagged cGAS were transfected with siRNAs as indicated. 24 h later cells were treated with Dox overnight and stained for lamin B1 (red), cGAS-FLAG (green) and DAPI (grey). One representative experiment out of 3 (**f**, **g**) or 2 (**a**, **b**, **c**, **d**) is shown. Mean and s.d. of n=20 individual MEFs at Day 0; n=20 individual MEFs at Day 7; n=42 individual WI-38 cells at Day 0; n=33 individual WI-38 cells at Day 7 are shown in (**b**). Mean and s.d. of n=3 independent experiments are shown in (**e**). *P* values were calculated by unpaired *t*-test (**b**) or one-way ANOVA (**e**) (\* *P* \< 0.05, \*\*\*\* *P* \< 0.0001, ns = not significant). Scale bar: 20 µm. Source data are available in [Supplementary Table 1](#SD10){ref-type="supplementary-material"}. Unprocessed original blots are shown in [Supplementary Fig. 7](#SD7){ref-type="supplementary-material"}.](emss-73252-f004){#F4}

![Engagement of cGAS is a common feature of multiple senescence triggers.\
(**a**) MEFs with the indicated genotypes were exposed to 12 Gy ionizing irradiation or stimulated with Palbociclib. Expression levels of Cxcl10 or protein levels of IL-6 were quantified by RT-qPCR or ELISA, respectively. (**b**) WI-38 cells (left panel) were exposed to 12 Gy ionizing irradiation or WI-38 ER:RAS cells (right panel) were treated with 4-OHT (500 nM) for 7 days. At day 7 (irradiated cells) or at day 3 (WI-38 ER:RAS cells) were transfected with a non-targeting control siRNA (si Control) or with siRNAs against cGAS (si cGAS \#1, si cGAS \#2). Expression of depicted genes was determined by RT-qPCR. (**c**) Expression of lamin B1 in individual WT MEFs exposed to irradiation (left panel) or treated with Palbociclib (right panel) for 7 days was determined by confocal fluorescence microscopy (CTCF = Corrected Total Cell Fluorescence). (**d**) Expression of lamin B1 in individual WI-38 cells exposed to irradiation (left panel) or WI-38 ER:RAS cells treated with 4-OHT was assessed by confocal fluorescence microscopy (CTCF = Corrected Total Cell Fluorescence). (**e**) cGAS KO MEFs carrying a Dox-inducible lentiviral vector containing a FLAG-tagged murine cGAS construct were irradiated (12 Gy) or treated with Palbociclib. 2 days post treatment cells were cultured in the presence of Dox overnight and then stained for FLAG (green) and nuclei (DAPI, grey). One representative experiment out of 2 experiments is shown (**e**) or mean and s.d. of n=51 individual control MEFs compared with n=48 individual irradiated MEFs (**c**, left); n=50 individual control MEFs compared with n=58 individual Palbociclib treated MEFs (**c**, right); n=177 individual control WI-38 cells compared with n=158 individual irradiated WI-38 cells (**d**, left); n=151 individual control WI-38 cells compared with n=87 individual 4-OHT treated WI-38 cells (**d**, right) are shown. Data shown in (**a**) and (**b**) are from n=2 independent experiments with the column representing the mean. *P* values were calculated by unpaired *t*-test (**c**, **d**) (\*\*\*\* *P* \< 0.0001, ns = not significant). Scale bar: 20 µm. Source data are available in [Supplementary Table 1](#SD10){ref-type="supplementary-material"}.](emss-73252-f005){#F5}

![cGAS contributes to cellular senescence *in vivo*.\
(**a**) Depicted mRNA levels of lungs from WT, cGAS KO and STING KO mice 16 weeks after irradiation are shown. (**b**) Representative liver stainings of Nras-, p21-, and SA-β-Gal 6 days after intrahepatic delivery of Nras^G12V^ or Nras^G12V/D38A^ into WT or cGAS KO mice are shown. Arrows indicate positive staining. (**c**, **d**) Quantification of Nras- or p21-positive cells (**c**) or expression of IL-6 protein levels or Cxcl10 mRNA levels (**d**) from (**b**) are shown. Mean of n=2 (WT mice untreated, cGAS KO mice) or mean and s.d of n=3 (WT mice irradiated, STING KO mice) (**a**), mean and s.d. of or n=4 (cGAS KO mice) or n=5 (WT mice) **(c**, **d**) or representative images (**b**) are shown. *P* values were calculated by two-way ANOVA (comparing genotypes or treatments) (\* *P* \< 0.05, \*\* *P* \< 0.01, ns = not significant). Scale bar: 100 μm. Source data are available in [Supplementary Table 1](#SD10){ref-type="supplementary-material"}.](emss-73252-f006){#F6}
